BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 19527023)

  • 1. Vitamin K3 disrupts the microtubule networks by binding to tubulin: a novel mechanism of its antiproliferative activity.
    Acharya BR; Choudhury D; Das A; Chakrabarti G
    Biochemistry; 2009 Jul; 48(29):6963-74. PubMed ID: 19527023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural naphthoquinone plumbagin exhibits antiproliferative activity and disrupts the microtubule network through tubulin binding.
    Acharya BR; Bhattacharyya B; Chakrabarti G
    Biochemistry; 2008 Jul; 47(30):7838-45. PubMed ID: 18597479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistein arrests cell cycle progression of A549 cells at the G(2)/M phase and depolymerizes interphase microtubules through binding to a unique site of tubulin.
    Mukherjee S; Acharya BR; Bhattacharyya B; Chakrabarti G
    Biochemistry; 2010 Mar; 49(8):1702-12. PubMed ID: 20085293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding.
    Gupta KK; Bharne SS; Rathinasamy K; Naik NR; Panda D
    FEBS J; 2006 Dec; 273(23):5320-32. PubMed ID: 17069615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding.
    Srivastava P; Panda D
    FEBS J; 2007 Sep; 274(18):4788-801. PubMed ID: 17697112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
    Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
    Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic activity and cytostatic mechanism of novel 2-arylbenzo[b]furans.
    Yang H; Pang JY; Cai YC; Xu ZL; Xian LJ
    J Pharm Pharmacol; 2006 Sep; 58(9):1281-7. PubMed ID: 16945188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane: type II estrogen binding sites and tubulin.
    ter Haar E; Hamel E; Balachandran R; Day BW
    Anticancer Res; 1997; 17(3C):1861-9. PubMed ID: 9216636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theaflavins depolymerize microtubule network through tubulin binding and cause apoptosis of cervical carcinoma HeLa cells.
    Chakrabarty S; Das A; Bhattacharya A; Chakrabarti G
    J Agric Food Chem; 2011 Mar; 59(5):2040-8. PubMed ID: 21323312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMK-TD-100, a novel microtubule modulating agent, blocks mitosis and induces apoptosis in HeLa cells by binding to tubulin.
    Bhattacharya S; Kumar NM; Ganguli A; Tantak MP; Kumar D; Chakrabarti G
    PLoS One; 2013; 8(10):e76286. PubMed ID: 24116100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of alpha-hydroxymethylated conjugated nitroalkenes for their anticancer activity: inhibition of cell proliferation by targeting microtubules.
    Mohan R; Rastogi N; Namboothiri IN; Mobin SM; Panda D
    Bioorg Med Chem; 2006 Dec; 14(23):8073-85. PubMed ID: 16891118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of beta-sitosterol on microtubular systems in cervical cancer cells].
    Wang L; Yang YJ; Chen SH; Ge XR; Xu CJ; Gui SQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2771-5. PubMed ID: 17199997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity.
    Zhang LH; Wu L; Raymon HK; Chen RS; Corral L; Shirley MA; Narla RK; Gamez J; Muller GW; Stirling DI; Bartlett JB; Schafer PH; Payvandi F
    Cancer Res; 2006 Jan; 66(2):951-9. PubMed ID: 16424030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bovine brain microtubule assembly in vitro by stypoldione.
    O'Brien ET; Jacobs RS; Wilson L
    Mol Pharmacol; 1983 Nov; 24(3):493-9. PubMed ID: 6633509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the hollow fiber assay for the determination of microtubule disruption in vivo.
    Suggitt M; Swaine DJ; Pettit GR; Bibby MC
    Clin Cancer Res; 2004 Oct; 10(19):6677-85. PubMed ID: 15475458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
    Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
    Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
    Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY
    J Pharmacol Exp Ther; 2007 Oct; 323(1):398-405. PubMed ID: 17660383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-cyano-3,12-dioxooleana-1,9(11)-diene-28-oic acid disrupts microtubule polymerization: a possible mechanism contributing to apoptosis.
    Couch RD; Ganem NJ; Zhou M; Popov VM; Honda T; Veenstra TD; Sporn MB; Anderson AC
    Mol Pharmacol; 2006 Apr; 69(4):1158-65. PubMed ID: 16407469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estramustine depolymerizes microtubules by binding to tubulin.
    Dahllöf B; Billström A; Cabral F; Hartley-Asp B
    Cancer Res; 1993 Oct; 53(19):4573-81. PubMed ID: 8402630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymoquinone inhibits microtubule polymerization by tubulin binding and causes mitotic arrest following apoptosis in A549 cells.
    Acharya BR; Chatterjee A; Ganguli A; Bhattacharya S; Chakrabarti G
    Biochimie; 2014 Feb; 97():78-91. PubMed ID: 24113316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.